Anti-PD1 antibody [NAT105]

• Supplier: Abcam
• Catalog: ab52587
• Prices: $404.00
• Sizes: 100 µg
• Host: Mouse
• Clonality: Monoclonal
• Isotype: IgG1
• Clone: NAT105
• Applications: FC IHC-F WB ICC/IF ICC/IF IP IHC-P
• Species Reactivities: Human
• Antigen: TY cells (human T/NK cell Leukemia)
• Description: Mouse Monoclonal
• Gene: PDCD1
• Conjugate: Unconjugated

Product images

Paraffin-embedded human tonsil section stained with ab52587 PD1 antibody at 1/50 dilution.

Anti-PD1 antibody [NAT105] (ab52587) at 1/50 dilution + YT cell line extracts

Double immunofluorescence staining of CD3 (green) and PD1 (red) on paraffin embedded tonsil.

Double immunoenzymatic staining of Ki67 (brown) and PD1 (red) on paraffin embedded tonsil.

Sample: Human tonsil cell extract Dilution: ab52587 antibody was used as 1:200 in 1x106 cells/tube. Anti-CD4 antibody was used as 1:200 dilution Anti-CD8 antibody was used as 1:200 dilution

Tissue Sample: Human Tonsil ab52587 diluted 1:100Incubation time: 30 mins

Product References

Cell distance mapping identifies functional T follicular helper cells in inflamed - Cell distance mapping identifies functional T follicular helper cells in inflamed

Liarski VM, Kaverina N, Chang A, Brandt D, Yanez D, Talasnik L, Carlesso G, Herbst R, Utset TO, Labno C, Peng Y, Jiang Y, Giger ML, Clark MR. Sci Transl Med. 2014 Apr 2;6(230):230ra46.

Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently - Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently

Smeltzer JP, Jones JM, Ziesmer SC, Grote DM, Xiu B, Ristow KM, Yang ZZ, Nowakowski GS, Feldman AL, Cerhan JR, Novak AJ, Ansell SM. Clin Cancer Res. 2014 Jun 1;20(11):2862-72.

Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and - Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and

Cogbill CH, Swerdlow SH, Gibson SE. Am J Clin Pathol. 2014 Jul;142(1):88-98.

Presence of antigen-experienced T cells with low grade of differentiation and - Presence of antigen-experienced T cells with low grade of differentiation and

Arguello RJ, Vigliano C, Cabeza-Meckert P, Viotti R, Garelli F, Favaloro LE, Favaloro RR, Laguens R, Laucella SA. PLoS Negl Trop Dis. 2014 Aug 21;8(8):e2989.

The histopathology of labial salivary glands in primary Sjogren's syndrome: - The histopathology of labial salivary glands in primary Sjogren's syndrome:

Szabo K, Papp G, Dezso B, Zeher M. Mediators Inflamm. 2014;2014:631787.

Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells - Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells

Kang MJ, Kim KM, Bae JS, Park HS, Lee H, Chung MJ, Moon WS, Lee DG, Jang KY. Transl Oncol. 2013 Jun 1;6(3):282-9. Print 2013 Jun.

Angioimmunoblastic T-cell lymphoma mice model. - Angioimmunoblastic T-cell lymphoma mice model.

Sato F, Ishida T, Ito A, Mori F, Masaki A, Takino H, Narita T, Ri M, Kusumoto S, Suzuki S, Komatsu H, Niimi A, Ueda R, Inagaki H, Iida S. Leuk Res. 2013 Jan;37(1):21-7.

Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced - Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced

Sznol M, Chen L. Clin Cancer Res. 2013 Mar 1;19(5):1021-34.

Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict - Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict

Kim JR, Moon YJ, Kwon KS, Bae JS, Wagle S, Kim KM, Park HS, Lee H, Moon WS, Chung MJ, Kang MJ, Jang KY. PLoS One. 2013 Dec 11;8(12):e82870.

Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved - Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved

French JD, Kotnis GR, Said S, Raeburn CD, McIntyre RC Jr, Klopper JP, Haugen BR. J Clin Endocrinol Metab. 2012 Jun;97(6):E934-43.